An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them. In my last column, I described the ...

Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

Embedding access tools at prescribing reduces manual enrollment, portal switching, and late activation, enabling faster ...

Wilhelm's comments describe a supply chain strategy built around flexibility, balancing inventory positioned close to ...

Geopolitical supply chain mapping identifies hidden dependencies across corridors, ports, airports, customs gateways, and carriers that can undermine continuity despite apparent supplier ...

How commercial trade groups are shifting from distribution execution to strategic partners shaping market access, launch readiness and commercial performance. This evolution reflects a broader shift ...

National polling indicates 54% of rural adults face at least one healthcare access barrier, underscoring that “access” is multidimensional and differs from coverage-centric system design. High cost ...

In this week's Pharma Pulse, Cardinal Health expands its at-Home Solutions business with two acquisitions, President Trump lays out a phased tariff schedule for generic drugs, and Novo Nordisk sues ...

Formulary exclusions have expanded from ~30 to ~1,400 in a decade, reflecting insurer responses to crowded classes and accelerating the migration of certain brands toward cash channels. Retail step ...

Amy Niles of the Patient Advocate Foundation revisits her 2026 outlook on prior authorization reform and the Medicare Prescription Payment Plan. Pharmaceutical Commerce continues its H1 Review/H2 ...